Application no. and date | 11167101.2 (espacenet) (Federated) (European Patent Register), 20060613 | Patent/reg. no. and date | DK/EP 2386294, 20150304 | Publication date | 20111116 | Priority no. and date | US 690010 P, 20050613, US 771279 P, 20060207 | EP pub. no. and date |
EP 2386294 20111116 | Effective date | | Applicant/owner | Gilead Sciences, LLC., 333 Lakeside Drive
Foster City, CA 94404, US | Applicant ref. no. | V133126 | Inventor | DAHL, Terrence, C., 1646 Kennewick Drive
Sunnyvale, CA 94087, US, JERZEWSKI, Robert, L., 162 North Street
Belle Mead, NJ 08502, US, OLIYAI, Reza, 1262 Crestview Drive
San Carlos, CA 94070, US, MENNING, Mark, M., 9 Hugo Street
San Francisco, CA 94122, US, YANG, Taiyin, 12134 Beauchamps Lane
Saratoga, CA 95070, US, HUSSAIN, Munir, A., 136 Belle Glades Lane
Belle Mead, NJ 08502, US, LIPPER, Robert, A., 7 Harbourton Ridge Drive
Pennington, NJ 08534, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/513 (2006.01) , A61K 31/535 (2006.01) , A61K 31/675 (2006.01) , A61K 9/24 (2006.01) , A61K 9/26 (2006.01) , A61P 31/18 (2006.01) , A61K 9/16 (2006.01) | Title | FARMACEUTISK ENHEDSDOSERINGSFORM OMFATTENDE TENOFOVIR DF, EMTRICITABIN,
EFAVIRENZ OG ET OVERFLADEAKTIVT MIDDEL | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|